Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways

by Zamanian M.; Qader Hamadneh L.A.; Veerakumarasivam A.; Abdul Rahman S.; Shohaimi S.; Rosli R.
Published in Cancer Cell International (2016)